Chemokine antagonist infusion attenuates cellular infiltration following spinal cord contusion injury in rat

Journal of Neuroscience Research

Volumn 59, Issue 1, 2000, Pages 63-73

  Ghirnikar, R S ^a,b   Lee, Y L ^a,b   Eng, L F ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antagonist; Apoptosis; Chemokine receptors; Spinal cord injury; vMIPII

Indexed keywords

CHEMOKINE RECEPTOR; HOE 33342; PROTEIN BCL 2; RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY INFILTRATE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

ANIMALS; APOPTOSIS; CHEMOKINES; CHEMOKINES, CC; FEMALE; GLIOSIS; INFLAMMATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE; SPINAL CORD; SPINAL CORD INJURIES;

EID: 0033985419     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000101)59:1<63::AID-JNR8>3.0.CO;2-W     Document Type: Article

References (44)

1. Adams DH, Lloyd AR. 1997. Chemokines: leukocyte recruitment and activation cytokines. Lancet 349:490-495.
2. Anderson DK. 1992. Chemical and cellular mediators in spinal cord injury. J Neurotrauma, Summer 9:143-145; discussion 145-146.
3. Beattie MS, Shuman SL, Bresnahan JC. 1998. Apoptosis and spinal cord injury. Neuroscientist 4:163-171.
4. Ben-Baruch A, Michiel DF, Oppenheim JJ. 1995. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 270:11703-11706.
5. Broadwell RD, Baker BJ, Ebert PS, Hickey WF, Villegas J. 1992. Intracerebral grafting of solid tissues and cell suspensions: the blood brain barrier and host immune response. Prog Brain Res. 91:95-102.
6. Broadwell RD, Baker BJ, Ebert PS, Hickey WF. 1994. Allografts of CNS tissue possess a blood brain barrier. III. Neuropathological, methodological and immunological considerations. Microsc Res Tech 27:471-494.
7. Chen A, Xu XM, Kleitman N, Bunge MB. 1996. Methylprednisolone administration improves axonal regeneration into Schwann cell grafts in transected adult rat thoracic spinal cord. Exp Neurol 138:261-276.
8. Chen S, Bacon KB, Li L, Garcia GE, Xia Y, Lo D, Thompson DA, Siani MA, Yamamoto T, Harrison JK, et al. 1998. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY. rats by vMIP-II. J Exp Med 188:193-198.
9. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. 1997. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys [published erratum appears in Nat Med 1997 Feb 3:240]. Nature Med 3:73-76.
10. Dijkstra CD, Dopp EA, Joling P, Kraal G. 1985. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2, and ED3. Immunology 54:589-599.
11. Dusart I, Schwab ME. 1994. Secondary cell death and the inflammatory response after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6:712-724
12. Eddleston M, Mucke L. 1993.. Molecular profile of reactive astrocytes, implications for their role in neurologic diseases. Neuroscience 54:15-36.
13. Elsner J, Petering H, Hochstetter R, Kimmig D, Wells TN, Kapp A, Proudfoot AE. 1997. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3. Eur J Immunol 271:2892-2898.
14. Eng LF, Reier PJ, Houle JD, 1987.. Astrocyte activation and fibrous gliosis: glial fibrillary acidic protein immunostaining of astrocytes following intraspinal cord grafting of fetal CNS tissue. In: FJ Seil, E Herbert, BM Carlson. editors. Progress in brain research, Vol. 71. Amsterdam: Elsevier. p 439-455.
15. Eng LF, Ghirnikar RS, Kou AL, Li JD, Lee YL. 1999. Chemokine inhibition in contused rat spinal cord with vMIPH as a receptor antagonist. J Neurochem 73 (Suppl.) S194A.
16. Faden Al. 1996. Pharmacological treatment of central nervous system trauma. Pharmacol Toxicol 78:12-17.
17. Ghirnikar RS, Lee YL, Li JD, Eng LF. 1998. Chemokine inhibition in rat stab wound brain injury using antisense oligodeoxynucleotides. Neurosci Lett 247:21-24.
18. Gong JH, Clark-Lewis I. 1995. Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2 terminal residues. J Exp Med 181:631-640.
19. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. 1997. An antagonist of monocyte chemoattractant protein 1 (MCP-I) inhibits arthritis in the MRL-lpr mouse model. J Exp Med, 186:131-137.
20. Horuk R. 1994. Molecular properties of the chemokine receptor family. Trends Pharmacol Sci 15:159-165.
21. Howard OM, Ben-Baruch A, Oppenheim JJ. 1996. Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends in Biotechnology 14(2):46-51.
22. Kledal TN, Rosenkilde MM, Coulin F, Simmons G, Johnsen AH, Alouani S, Power CA, Luttichau HR, Gerstoft J, Clapham PR, Clark-Lewis I, Wells TNC, Schwartz TW. 1997. A broad spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277: 1656-1659.
23. Lee YL, Bao JX, Ghirnikar RS, Eng LF. 1997. Factors induced after rat spinal cord injury. J Neurochem 69(Suppl):S144C.
24. Lee YL, Shih K, Bao P, Eng LF. 1999. Cytokine/Chemokine expression in contused rat spinal cord. Neurochem Int (in press).
25. Lou J; Lenke LG; Ludwig FJ; O'Brien MF. 1998. Apoptosis as a mechanism of neuronal cell death following acute experimental spinal cord injury. Spinal Cord 36):683-690.
26. McTigue DM, Tani M, Krivacic K, Chernosky A, Kelner GS, Maciejewski D, Maki R, Ransohoff RM, Stokes BT. 1998a. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J Neurosci Res 53:368-376.
27. McTigue DM; Horner PJ; Stokes BT; Gage FH.1998b. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 8:5354-5365.
28. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama Kei-ichi, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S, Loh DY. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506-1510.
29. Murphy P. 1994. The molecular biology of leukocyte chemoattractant receptors. Ann Rev Immunol 12:593-633.
30. Murphy GM Jr., Jia XC, Yu ACH, Lee YL, Tinklenberg JR, Eng LF. 1993. Reverse transcription-PCR for quantification of mRNA in primary astrocyte cultures. J Neurosci Res 35:643-651.
31. Plater-Zyberk C, Hoogewerf AJ, Proudfoot AE, Power CA, Wells TN. 1997. Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol Lett 57:117-120.
32. Popovich PG, Wei P, Stokes BT. 1997. Cellular inflammatory responses after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464.
33. Raghupathi R, Fernandez SC, Murai H, Trusko SP, Scott RW, Nishioka WK, McIntosh TK.1998. BCL-2 overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice. J Cereb Blood Flow Metab 18:1259-1269.
34. Shih K, Lee YL, Eng LF. 1997. Cytokine/Chemokine expression in rat spinal cord contusion model. Seventh International Symposium on Neural regeneration. P74, Pacific Grove, CA (Dec 10-14). Sponsored by the VA Office of Regeneration Research Programs.
35. Soares HD, Hicks RR, Smith D, McIntosh TK. 1995. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15:8223-8233.
36. Sozzani S, Allavena P, Proost P, Van Damme J, Mantovani A. 1996. Chemokines as targets for pharmacological intervention. In: Jucker E, editor. Progress in drug research, vol. 47. Basel: Birkhauser Verlag, p 53-80.
37. Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT. 1998. Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 152:74-87.
38. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. 1994. Macrophages and angiogenesis. J Leuk Biol 55:410-422.
39. Takahashi K, Schwarz E, Ljubetic C, Murray M, Tessler A, Saavedra RA. 1999. DNA plasmid that codes for human Bcl-2 gene preserves axotomized Clarke's nucleus neurons and reduces atrophy after spinal cord hemisection in adult rats. J Clomp Neurol 404:159-171.
40. Wrathall JR, Pettegrew RK, Harvey F. 1985. Spinal cord contusion in the rat: production of graded, reproducible, injury groups. Exp Neurol 88: 108-122.
41. Yakovlev AG; Faden AI. 1944. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol Chem Neuropathol 23:179-190.
42. Yong C, Arnold PM, Zoubine MN, Citron BA, Watanabe I, Berman NE, Festoff BW. 1998. Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma 15:459-472.
43. Zagorski J, Wahl SM.1997. Inhibition of acute peritoneal inflammation in raw by a cytokine-induced neutrophil chemoattractant receptor antagonist. J Immunol 159:1059-1062.
44. Zhang YJ, Rutledge BJ, Rollins BJ. 1994. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. J Biol Chem 269:15918-15924.